Contract Pharma Manufacturing Solutions

1. Psychedelics: Drug Development Capabilities 10/30/2023

   Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.

2. European Center Of Excellence For Clinical Biologics

   Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.

3. Manufacturing GTP And GMP 3/21/2024

   Learn how a one-stop solution for your cell therapy needs can help ensure efficiency, cost-effectiveness, and faster patient treatment. Our Draw-to-Thaw® service streamlines the entire process.

4. Small Molecule CDMO Services 9/26/2024

   We specialize in the custom development and manufacturing of small molecule APIs, intermediates, and RSMs, offering scalable solutions from kilograms to multi-ton quantities.

5. Improving CLD Efficiency With An Innovative Platform

   Cell line development (CLD) bottlenecks can stall progress on the path to clinical trials. Examine how a novel CLD platform can accelerate development for efficient protein and vaccine production.

6. Pre-Formulation And Material Sciences 3/3/2022

   Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.

7. Contract Drug Development, Manufacturing, And Analytical Testing 1/29/2024

   Explore our collection of capabilities, including liquid-filled capsules, band/sealing technologies, powder, over-encapsulated capsules, topical formulations, and clinical and blister packaging.

8. Small-Molecule: Development And Manufacturing 3/18/2025

   With over three decades of experience, Curia Small Molecule specializes in process chemistry, process safety, scale-up, and cGMP API manufacturing for preclinical, clinical, and commercial supply.

9. Integrated Operations Produce Top-Tier Raw Materials

   An integrated supply chain, with transparency among sponsors and suppliers, ensures that regulatory starting materials (RSMs) are well characterized and free of impurities that can impact the final drug product.

10. Integrated Solutions For Your Mammalian-Based Biologics 6/2/2025

    A leading CDMO offers integrated development and manufacturing solutions for mammalian-based biologics, including mAbs, ADCs, and biosimilars, with strong quality, flexibility, and regulatory compliance.